Declan Doogan
Director at Tenax Therapeutics, Inc. (TENX) since February 2021
Declan Doogan has filed 15 insider reports with the SEC since May 2021, as director at Tenax Therapeutics, Inc. (TENX) and director at Biohaven Pharmaceutical Holding Co Ltd. (BHVN). In the last 12 months Declan Doogan bought $102K of stock on the open market. In the latest filing, on September 18, 2026, Declan Doogan bought 53,000 shares of Tenax Therapeutics, Inc. (TENX) for $102K at an average of $1.92.
- Filings
- 15
- Companies
- 2
- Bought on market
- $102K
- Sold on market
- $13.3M
Companies where Declan Doogan is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Directorsince February 2021 | 55,274 | $102K | $1.92 | $1.42-26% | Sep 18, 2026 | ||
| Director | 0 | $13.3M | $13.24 | Feb 12, 2022 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Sep 16, 2026+$102KTENXDirector Doogan Declan bought $101,760 worth of shares (53,000 units at $1.92), increasing direct ownership by 2,331% to 55,274 unitsForm 4Open-market purchase
- Jan 9, 2026TENXSEC Form 4 filed by Director Doogan DeclanForm 4Grant or award
- Jul 1, 2025TENXSEC Form 4 filed by Director Doogan DeclanForm 4Grant or award
- Dec 10, 2024TENXSEC Form 4 filed by Director Doogan DeclanForm 4Grant or award
- Aug 11, 2022TENXSEC Form 4: Doogan Declan gifted 567,871 shares and received a gift of 567,871 shares, increasing direct ownership by 18% to 3,637,871 unitsForm 4Gift
- Jun 9, 2022TENXSEC Form 4 filed by Doogan DeclanForm 4Grant or award
- Nov 30, 2021BHVNSEC Form 5: Doogan Declan gifted 1,264,051 shares and received a gift of 1,264,051 shares, closing all direct ownership in the companyForm 5GiftDiscretionary plan transaction
- Jun 16, 2020-$2.83MBHVNSEC Form 4: Doogan Declan sold $2,829,152 worth of shares (41,306 units at $68.49) (Amendment)Form 4Open-market sale
- Jun 12, 2020-$3.32MBHVNSEC Form 4: Doogan Declan sold $3,321,623 worth of shares (50,953 units at $65.19) (Amendment)Form 4Open-market sale
- Nov 29, 2021-$2.77MBHVNSEC Form 4: Doogan Declan sold $2,766,433 worth of shares (24,525 units at $112.80), decreasing direct ownership by 3% to 870,648 unitsForm 4Open-market sale
- Nov 16, 2021-$4.4MBHVNSEC Form 4: Doogan Declan exercised 559,000 shares at a strike of $7.87 and sold $4,402,385 worth of shares (37,740 units at $116.65), increasing direct ownership by 139% to 895,173 unitsForm 4Exercise or conversion of a derivativeOpen-market sale
- Jun 30, 2021TENXSEC Form 4: Doogan Declan gifted 567,871 units of Common Stock, decreasing direct ownership by 18% to 2,502,129 unitsForm 4Gift
- Jun 11, 2021TENXSEC Form 4: Doogan Declan converted options into 3,070,000 units of Common Stock, increasing direct ownership by 541% to 3,637,871 unitsForm 4Grant or awardExercise or conversion of a derivative
- Feb 25, 2021TENXSEC Form 3: Doogan Declan claimed ownership of 3,070 units of Series B Preferred Stock and claimed ownership of 567,871 units of Common StockForm 3New insider
- May 5, 2021BHVNSEC Form 4 filed by Doogan DeclanForm 4Grant or award
Compare Declan Doogan with
- Declan Doogan vs Kimberly Gentile1 shared
- Declan Doogan vs Christopher Thomas Giordano1 shared
- Declan Doogan vs Thomas R Staab II1 shared
- Declan Doogan vs Kishan Mehta1 shared
- Declan Doogan vs Gregory Bailey1 shared
- Declan Doogan vs Michael Thomas Heffernan1 shared
Other insiders at the same companies
- Kimberly GentileBHVN
- Christopher Thomas GiordanoTENX
- Thomas R Staab IITENX
- ADAR1 Capital Management, LLCTENX
- John YetimogluBHVN
- Warren Karl VollesBHVN
- Kishan MehtaBHVN
- Gregory BaileyBHVN
- Michael Thomas HeffernanBHVN
- Irina AntonijevicBHVN
- John W ChildsBHVN
- Robert J HuginBHVN
- Julia P GregoryBHVN
- Matthew ButenBHVN
- George C. ClarkBHVN
- Bruce CarBHVN
Questions about Declan Doogan
- What is Declan Doogan's role at Tenax Therapeutics, Inc.?
- Declan Doogan reports to the SEC as director at Tenax Therapeutics, Inc. (TENX), according to the latest filing on September 18, 2026. Declan Doogan has also filed as director at Biohaven Pharmaceutical Holding Co Ltd. (BHVN).
- How many shares does Declan Doogan own?
- After the latest filing that states it, Declan Doogan directly owned 55,274 shares of Tenax Therapeutics, Inc. (TENX). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Declan Doogan bought or sold stock recently?
- The most recent open-market purchase was on September 16, 2026: bought 53,000 shares of Tenax Therapeutics, Inc. (TENX) for $102K at an average of $1.92. The most recent open-market sale was on June 16, 2020: sold 41,306 shares of Biohaven Pharmaceutical Holding Co Ltd. (BHVN) for $2.83M at an average of $68.49.
- How do I get alerts when Declan Doogan files?
- Follow Declan Doogan on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Declan Doogan filed 1 time in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Declan Doogan (SEC CIK 0001704234). Totals count each trade once, skipping amendments whose original is on file, from May 7, 2021 on. View on SEC EDGAR